Molecular Transport Medium Market Trends

  • Report ID: 4251
  • Published Date: Jun 24, 2024
  • Report Format: PDF, PPT

Molecular Transport Medium Market Trends

Growth Drivers

  • Rise in the Number of Infectious Diseases Worldwide - According to WHO, the number of infectious and parasitic diseases touched 7.2 million in 2018 globally. Furthermore, in 2019, the number of cases of various infectious disease was estimated to rise globally such as, tuberculosis (8000), meningococcal disease (400), salmonella (55,000), and Lyme disease (35,000).Molecular transport medium is most suitable for the diagnosis of infectious diseases since it prevents the spreading of infection among the healthcare staff. MTM are known to preserve the sample to its initial state by keeping them close as mush as required. This process becomes helpful in preventing the spread of viruses in the environment for days and weeks. Hence, this factor is projected to hike the market growth over the forecast period.
  • Increasing Number of Diagnostic Tests - More than 3 billion Vitro diagnostic tests are conducted every year (both FDA-reviewed and lab-developed tests) across the globe.
  • Rise In Experiments in Laboratories and Research Institutes - According to the data by the World Bank, there were 1597 researchers involved in research and development activities per 1,000,000 people, as of 2018, up from 1412 per million in 2015.
  • Rising Awareness for the Health of Co-Workers in a Laboratory - Total fatal occupational injuries in healthcare practitioners and technical occupations decreased from 60 in 2016 to 51 in 2020, and healthcare support occupations raised from 30 in 2016 to 44 in 2020. Molecular transport medium is the best solution to prevent the spread of infection in co-workers and owing to this, healthcare providers highly prefer MTMs.
  • Growing Expenditure for R&D Activities – based on the data released by the World Bank, the health expenditure for research and development was stated to reach 2.63% up from 2.2% in 2028. Research and development of molecular transport medium is at its peak and growing health expenditure has been proved to be very beneficial for it.

Challenges

  • Unpredictable Nature of Seasonal Infections - There are multiple infectious diseases that spread in global population and their nature of spreading and affecting the can be quite unpredictable. This condition makes the molecular transport medium as ordinary as other mediums are. Hence, this factor can limit the market growth over the forecast period.
  • High Risk of False Results by Molecular Medium
  • Uncertain Occurrence of Infections Leading to the Adoption of a Conservative Approach

Molecular Transport Medium Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

1.1%

Base Year Market Size (2023)

USD 1.01 Billion

Forecast Year Market Size (2035)

USD 1.16 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4251
  • Published Date: Jun 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of molecular transport medium is estimated at USD 1.02 Billion.

The molecular transport medium market size was over USD 1.01 Billion in 2023 and is set to cross USD 1.16 Billion by the end of 2036, growing at more than 1.1% CAGR during the forecast period i.e., between 2024-2036. Rise in the number of infectious diseases worldwide and rising awareness for the health of co-workers in a laboratory are the major factors driving the market growth.

North America is projected to hold majority industry share by 2036, attributed to improvement in the availability of new diagnostic test kits and drugs in pharmacies and retail shops as OTC drugs.

Thermo Fisher Scientific Inc, Becton, Dickinson and Company, Medical Wire & Equipment Ltd, Titan Biotech Ltd., EKF Diagnostics Holdings plc, Trinity Biotech Plc., Puritan Medical Products Company LLC, Longhorn Vaccines and Diagnostics, LLC, Mylab Discovery Solutions Pvt. Ltd., 2B Scientific Limited
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample